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ABSTRACT
Background: Patterns of wheezing during early childhood
may indicate differences in aetiology and prognosis of
respiratory illnesses. Improved characterisation of
wheezing phenotypes could lead to the identification of
environmental influences on the development of asthma
and airway diseases in predisposed individuals.
Methods: Data collected on wheezing at seven time
points from birth to 7 years from 6265 children in a
longitudinal birth cohort (the ALSPAC study) were
analysed. Latent class analysis was used to assign
phenotypes based on patterns of wheezing. Measures of
atopy, airway function (forced expiratory volume in 1 s
(FEV1), mid forced expiratory flow (FEF25-75)) and
bronchial responsiveness were made at 7–9 years of age.
Results: Six phenotypes were identified. The strongest
associations with atopy and airway responsiveness were
found for intermediate onset (18 months) wheezing (OR
for atopy 8.36, 95% CI 5.2 to 13.4; mean difference in
dose response to methacholine 1.76, 95% CI 1.41 to 2.12
%FEV1 per mmol, compared with infrequent/never wheeze
phenotype). Late onset wheezing (after 42 months) was
also associated with atopy (OR 6.6, 95% CI 4.7 to 9.4)
and airway responsiveness (mean difference 1.61, 95% CI
1.37 to 1.85 %FEV1 per mmol). Transient and prolonged
early wheeze were not associated with atopy but were
weakly associated with increased airway responsiveness
and persistent wheeze had intermediate associations with
these outcomes.
Conclusions: The wheezing phenotypes most strongly
associated with atopy and airway responsiveness were
characterised by onset after age 18 months. This has
potential implications for the timing of environmental
influences on the initiation of atopic wheezing in early
childhood.
Asthma is a complex heterogeneous disease com-
prising a number of discrete phenotypes, such that
the term ‘‘asthma’’ has recently been called into
question.1 Cohort studies followed to adulthood
have reported that more severe childhood wheezing
phenotypes are less likely to remit in later life.2–4
Pulmonary function abnormalities associated with
persistent wheezing become established during
early childhood and track to adult life, suggesting
that early life exposures are critical in determining
the onset and natural history of wheezing ill-
nesses.3 5 An improved understanding of these
phenotypes is therefore of fundamental impor-
tance to studies of risk factors for asthma and
wheezing illnesses in children.
In a seminal report based on the Tucson
Children’s Respiratory Study, Martinez and col-
leagues proposed three patterns of wheezing
during the first 6 years of life6 leading to the
concepts of transient early wheezing in the first
3 years, non-atopic wheezing in the preschool
years and IgE-mediated wheeze or asthma.7
Although these have served as useful models of
wheezing phenotypes in early childhood, there is
evidence that phenotypes diverge earlier than
3 years8 and a recent report described variations
in immune responses within seemingly homo-
geneous phenotypes of IgE-mediated asthma.9 We
used a novel symptom-driven approach to define
wheezing phenotypes using repeat measurements
of wheeze during the first 7 years of childhood in a
large population-based birth cohort study, the
Avon Longitudinal Study of Parents and Children
(ALSPAC). We investigated associations of these
phenotypes with physician-diagnosed asthma and
objectively measured atopy and airway function at
age 7–9 years.
METHODS
Participants
ALSPAC is a longitudinal population-based birth
cohort study that recruited 14 541 pregnant
women resident in Avon, UK with expected dates
of delivery 1 April 1991 to 31 December 1992.
There were 14 062 liveborn children. The study
protocol has been described previously10 11 and
further details are shown on the ALSPAC website
(http://www.alspac.bris.ac.uk).
Data collection
At 6, 18, 30, 42, 54, 69 and 81 months after birth,
study mothers were sent a self-completion ques-
tionnaire about the health of their child. They were
asked to report the occurrence of 15 common
symptoms, including wheezing, in the previous
12 months (6 months for the initial questionnaire)
and, if present, whether they consulted a doctor. In
a separate section they were asked whether in the
past 12 months (6 months in the first question-
naire) their child had ‘‘wheezing with whistling on
the chest when (s)he breathed’’. At 91 months of
age mothers were asked in a separate questionnaire
to report if a physician had ever told them that
their child had asthma.
The atopic status of the children was determined
at 7–8 years of age by skin prick test responses to a
panel of up to 12 common allergens including
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house dust mite (Dermatophagoides pteronyssinus), mixed grasses
and cat (ALK; Abello´, Hoersholm, Denmark). Sensitisation to
one of these three allergens has been shown to identify 95% of
all sensitised children in this population.12 A positive response
was defined as a mean weal diameter of >2 mm with an absent
response to negative control solution, and atopy was defined as
a positive response to one or more of house dust mite, cat or
grass pollen. Mothers were asked to report a personal history of
asthma or allergy in a questionnaire administered during
pregnancy.
At 8–9 years of age, lung function was measured by
spirometry (Vitalograph 2120, Maids Moreton, UK) according
to American Thoracic Society criteria.13 Flow-volume curves
were reviewed by one respiratory physician (JH) to ensure
adherence to standards, resulting in the rejection of 338 (4.6%)
measurements and the correction of 883 (11.5%) where the
automated programme had selected an inappropriate curve.
Each variable (forced expiratory volume in 1 s (FEV1), forced
vital capacity (FVC) and mid forced expiratory flow (FEF25–75))
was converted to sex-, age- and height-adjusted standard
deviation units.14 Airway responsiveness to methacholine was
measured using the method of Yan et al15 and expressed for each
subject as the dose-response slope of FEV1 (percentage decline
from baseline) per mmol methacholine.
Statistical methods
Wheeze was defined as present if the response to either question
about wheezing was ‘‘yes’’ and absent if the response to both
was ‘‘no’’. All other combinations were classed as missing
(1.3%). As there were two levels of response to questions about
wheeze at seven time points, there were 27 = 128 different
patterns of wheezing possible. Therefore, to derive phenotypes
with similar wheezing patterns over time, we used latent class
analysis. This is a statistical method for finding subtypes of
related cases (latent classes) from multivariable categorical data
(in this case, responses to wheezing questions across seven time
points). Briefly, individuals were clustered into a number of
discrete latent classes (phenotypes) on the basis of the pattern
of responses to each of the wheezing questions. The latent class
model aims to determine the minimum number of latent classes
that describe the observed patterns of responses in the data.16 A
full description of the latent class analysis used in this study and
methods used to evaluate the best fitting model are shown in
the online supplement. The posterior probability of each
individual belonging to a particular phenotype was estimated
and, from these data, the estimated prevalence of wheeze at
each time point was calculated for each phenotype.
Children with complete reports of wheezing at all seven time
points were included in the analyses. Logistic and linear
regression was used to estimate associations of phenotype
membership with physician-diagnosed asthma and objective
measurements of atopy, lung function and bronchial respon-
siveness in mid childhood and with maternal self-reported
asthma and allergy. As latent class analysis is robust to missing
data and misclassification of data items such as faulty recall of
wheezing episodes, we repeated all analyses in children who
returned questionnaires at two or more time points.
All analyses were done using MPlus 4.1 software (Muthe´n &
Muthe´n, Los Angeles, 2006).
RESULTS
Of 11 678 children with reports of wheezing on at least two
occasions, 6265 (54%) had complete data. The characteristics of
the study population are shown in table 1. Children with
complete data were less likely to come from socially deprived
backgrounds and had lower prevalence of reported wheezing in
early childhood than children with missing data.
Comparison of Bayesian information criteria (BIC; see online
supplement) suggested that a model with six phenotypes
provided the best fit (BIC from models with 3, 4, 5, 6 and 7
phenotypes were 34709, 34357, 34304, 34275 and 34285,
respectively). Bootstrap likelihood ratio tests (BLRT) suggested
Table 1 Characteristics of the study population with complete data on wheezing from birth to 81 months
(n = 6265) compared with those with missing data
Children with complete
data on wheezing
(n = 6265)
Children with 2–6
observations (n = 5413)
Children with 0–1
observations (n = 2384)
n/total % n/total % n/total %
Girls 3029/6265 48 2623/5413 48 1138/2382 48
Demographic data
Rented house 973/6143 16 1583/5116 31 943/1483 51
Mother not married 1041/6202 17 1427/5154 28 758/1864 41
Overcrowding 218/6088 4 404/5019 8 260/1771 15
One or more siblings 3289/6125 54 2862/5069 56 1043/1813 58
Low maternal education* 3496/6183 57 3531/4975 71 1038/1309 79
Teenage mother 89/6265 1 303/5413 6 263/2384 11
Mother manual occupation 793/5380 15 933/3851 24 284/868 33
Partner manual occupation 2158/5728 38 2112/4285 49 583/985 59
Prevalence of wheeze
At 6 months 1506/6265 24 1338/4644 29 165/507 33
6 months 1506/6265 24 1338/4644 29 165/507 33
18 months 1645/6265 26 1334/4574 29 43/138 31
30 months 1336/6265 21 905/3671 25 21/54 39
42 months 1051/6265 17 705/3705 19 5/34 15
54 months 1128/6265 18 644/3122 21 7/23 30
69 months 938/6265 15 389/2327 17 1/9 11
81 months 852/6265 14 273/2127 13 4/11 36
*Low maternal education classified as ‘‘O’’ level or below (equivalent to school leaving certificate at 16 years in the UK).
Paediatric asthma
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a further improvement in fit comparing models with seven and
eight phenotypes in cases with complete data only; analyses of
data from children with at least two measures of wheezing from
6 to 81 months suggested—based on both BIC and BLRT—that
a six-phenotype model provided the best fit. We therefore
selected the more parsimonious solution and based further
analyses on six-phenotype models for both datasets.
The estimated prevalence of wheezing at each time point in
the six phenotypes is shown in fig 1. Hereafter, we describe the
phenotypes as follows:
c 1: Never/infrequent wheeze (59.3% of children) had
approximately 10% prevalence of wheezing at 6 months
with declining prevalence of sporadic wheeze thereafter and
included subjects (76.5% of this category) who never
reported wheeze.
c 2: Transient early wheeze (16.3%) had 50–60% prevalence
up to 18 months, declining to low prevalence from
42 months.
c 3: Prolonged early wheeze (8.9%) had a peak prevalence of
around 65% at 30 months, declining to low prevalence from
69 months.
c 4: Intermediate onset wheeze (2.7%) had a low prevalence
up to 18 months, rising rapidly to high prevalence from age
42 months.
c 5: Late onset wheeze (6.0%) had approximately 20%
prevalence up to 42 months, rising to 50% or higher
prevalence thereafter.
c 6: Persistent wheeze (6.9%) had 65% prevalence at 6 months
with approximately 90% prevalence thereafter.
Patterns of wheezing were similar in 11 678 children with
missing data (see fig E1 in online supplement).
Association of wheezing phenotypes with atopy and parental
asthma/allergy
Table 2 shows associations of wheezing phenotypes with skin
test responses at age 7–8 years. Intermediate onset wheeze, late
onset wheeze and persistent wheeze were strongly associated
with atopy. Neither of the early wheezing phenotypes was
associated with atopy or specific allergen sensitisation.
Intermediate onset wheezing showed the strongest associations
with atopy and with sensitisation to cat and house dust mite (D
pteronyssinus) allergens. Late onset wheezing was also strongly
associated with cat and house dust sensitisation and had the
strongest association with grass pollen sensitisation.
Maternal self-reported asthma and allergy were positively
associated with all wheezing phenotypes compared with
infrequent wheeze (table 3). The strongest association with
both maternal phenotypes was seen with persistent wheeze.
Association of wheezing phenotypes with asthma and lung
function
All wheezing phenotypes were associated with physician-
diagnosed asthma by age 91 months compared with the
never/infrequent wheeze phenotype. The proportion of subjects
with physician-diagnosed asthma and odds ratios (OR) (95%
confidence interval (CI)) were as follows: transient early wheeze
8.5%, OR 2.5 (95% CI 1.5 to 4.1); prolonged early wheeze 36%,
OR 14.9 (95% CI 10.7 to 20.7); intermediate onset wheeze
92.8%, OR 326 (95% CI 138 to 770); late onset wheeze 76.2%,
OR 85 (95% CI 56 to 128); persistent wheeze 92.1%, OR 308
(95% CI 186 to 510).
Compared with the late onset phenotype, the intermediate
onset phenotype was associated with a higher prevalence of
doctor-diagnosed asthma (OR 3.9, 95% CI 1.1 to 13.2).
Similarly, compared with the transient early phenotype, the
prolonged early phenotype had an OR of asthma at 91 months
of 6.0 (95% CI 3.5 to 10.3), reflecting the marked difference in
prevalence of doctor-diagnosed asthma (9% and 36%, respec-
tively) in the two groups.
Table 4 shows associations of wheezing phenotypes with
lung function and airway responsiveness at 8–9 years of age. All
phenotypes were associated with decrements of FEV1 and
FEF25–75 and increased airway responsiveness compared with
never/infrequent wheeze. The greatest decrements were asso-
ciated with prolonged early, intermediate onset and persistent
wheezing. Airway responsiveness was highest in the intermedi-
ate and late onset phenotypes.
Compared with late onset wheezing, the intermediate onset
phenotype was associated with decrements of FEV1 and FEF25–75
of 0.33 (95% CI 0.10 to 0.55) and 0.28 (95% CI 0.05 to 0.52)
standard deviations, respectively. There was also a decrement in
mid-expiratory flow (mean difference for FEF25–7520.22 SD units
(95% CI 20.34 to 20.11) in the prolonged early wheezing group
compared with the transient early wheezing group.
Never wheeze versus infrequent wheeze
As 2979/3896 subjects (76.5%) assigned to the never/infrequent
wheeze phenotype had never reported wheeze, the associations
with objective outcomes of these children were compared with
the 917 subjects assigned to this group who reported at least one
episode of wheeze. The never wheeze group had higher FEV1
(mean difference 0.14 SD units (95% CI 0.05 to 0.22)) and
FEF25–75 (mean difference 0.18 SD units (95% CI 0.10 to 0.27))
and lower airway responsiveness (20.30 percentage FEV1 per
mmol methacholine (95% CI 20.13 to 20.47)) than those with
at least one reported episode of wheeze. There were no
differences in the prevalence of atopy or individual skin prick
test responses between these two groups.
Associations of wheezing phenotypes with other outcomes in
children with missing data
The associations of wheezing phenotypes with maternal
asthma and with later childhood outcomes in 11 678 children
who returned at least two questionnaires on wheezing are
shown in tables E3–E5 in the online supplement. These gave
very similar results to the analyses based on children with
complete data on wheezing between 6 and 81 months of age.
Figure 1 Estimated prevalence of wheezing at each time point from
birth to 81 months for each of the six wheezing phenotypes identified by
latent class analysis in 6265 children with complete data.
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DISCUSSION
Using data on reported wheezing collected at frequent intervals
during the first 7 years in a large population-based birth cohort,
we have identified six childhood wheezing phenotypes and
quantified their associations with objective measures of atopy
and lung function in mid-childhood. Two of these phenotypes
have not been described previously. Prolonged early wheeze
(around 9% of children) was characterised by wheezing from
age 6 to 54 months with low prevalence from age 69 months
onwards. It was not associated with aeroallergen sensitisation
but was associated with increased airway responsiveness and
lower lung function at ages 8–9 years compared with the never/
infrequent wheeze phenotype. Intermediate onset wheeze
(around 2.5% of children) had onset between ages 18 and
42 months. This phenotype was characterised by the strongest
association with atopy (particularly skin prick sensitivity to D
pteronyssinus and cat allergen), lower lung function and higher
levels of airway responsiveness compared with the never/
infrequent wheeze phenotype. Such associations (represented
figuratively in table 5) may reveal differing aetiological or
environmental influences on the inception of asthma in young
children.
Although the phenotypes identified here have similarities to
previously reported patterns of early childhood wheezing, there
were differences in their associations with objective outcomes.
In the Tucson study, children with persistent and late onset
wheeze had the strongest associations with atopy and those
with persistent and transient early wheeze had the greatest
decrements of lung function at age 6 and 11 years,5 with only
persistent wheeze being positively associated with increased
airway responsiveness at 11 years.17 Our results challenge these
paradigms in that intermediate onset wheezing was most
strongly associated with atopy and airway responsiveness in our
study, although it should be noted that this pattern would have
been included in the persistent wheeze phenotype as defined by
the Tucson group. Persistent wheeze in the present study was
less strongly associated with atopy than intermediate or late
onset wheeze, but was associated with similar lung function
deficits to intermediate onset wheeze, suggesting that persistent
wheeze may represent a mixture of structural airway abnorm-
alities associated with early onset wheezing and atopic wheeze
that develops during early childhood.
In order to interpret the relevance of these findings to the
heterogeneity of early childhood wheezing, it is necessary to
appreciate the advantages and limitations of the latent class
method used to identify the phenotypes in this study. As the
term ‘‘latent classes’’ implies, these are not directly observed
phenomena but were constructed post hoc on the basis of the
pattern of responses to wheezing over a fixed number of
observation periods. These methods are therefore not applicable
to predicting the natural history of wheezing in individualTa
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Table 3 Associations of wheezing phenotypes with maternal self-
reported asthma and allergy in 6133 children with complete data on
wheezing and maternal history of asthma/allergy
Wheezing
phenotype
Maternal asthma
Odds ratio (95% CI)
Maternal allergy
Odds ratio (95% CI)
Transient early 2.26 (1.62 to 3.15) 1.37 (1.11 to 1.71)
Prolonged early 2.68 (1.89 to 3.78) 1.79 (1.40 to 2.29)
Intermediate 3.54 (2.21 to 5.67) 1.53 (1.05 to 2.22)
Late 2.37 (1.58 to 3.57) 1.41 (1.06 to 1.88)
Persistent 4.17 (3.12 to 5.56) 2.09 (1.67 to 2.62)
Never/infrequent 1 (reference) 1 (reference)
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subjects. Each child was assigned a probability of membership of
each class based on their overall wheezing history. As shown in
table E1 in the online supplement, some children had a high
probability of membership of a single class while the assignment
of others was less certain. This becomes increasingly evident in
analyses including children with some missing observations of
wheeze. Children with clear patterns of reported wheezing,
such as those who always or never wheezed, had the highest
probability of belonging to a single phenotype and therefore
contributed the greatest weight to analyses of associations of
these phenotypes with other outcomes. The advantage of the
latent class approach is that the phenotypes were not
constrained by prespecified notions of their number or nature;
these were determined by the patterns observed in the data.
Clear and interpretable associations of the different phenotypes
with physician-diagnosed asthma and with objective measures
of atopy and lung function at ages 7–9 years confirmed the
utility of the approach. However, we acknowledge that the
question of whether these phenotypes represent discrete
pathophysiological entities cannot be resolved by the present
analysis. For instance, it is conceivable that prolonged and
transient early wheezing represents different severities of the
same broad phenotype, with the more severe phenotype being
associated with longer duration of wheeze and poorer prognosis.
Future analyses of associations of these derived phenotypes
with early life exposures that may contribute to their aetiology
will help to address some of these issues.
An advantage of our study compared with previous cohort
studies of the natural history of wheezing is its larger size,
which allows investigation of associations of wheezing pheno-
types with different measures of atopy and lung function,
despite the fact that some phenotypes represented relatively
small proportions of children. For comparison, the Tuscon
Study reported on 826 children during the first 6 years,6 the
Dunedin study on 613 subjects with complete respiratory data
at 9–26 years,3 the Perth study of infant lung function reported
outcomes at 11 years in 183 infants18 and a cohort of 2860
infants in Perth reported on asthma to age 6 years.19
There were also a number of limitations of our data. In
common with most cohort studies,20 loss to follow-up was
greater in children from more socially deprived backgrounds.
Given known associations of social deprivation with early
childhood wheezing,21 it is likely that children excluded because
of missing data had a higher proportion of transient early
wheezing than those included. We addressed this problem more
comprehensively than previous cohort studies because we found
similar results when we repeated latent class analyses using
11 678 children with two or more observations of wheeze.
The wheeze questionnaire that was devised for the ALSPAC
study in 1991 contains similar questions to the ISAAC
questionnaire now in common use.22 Care was taken to resolve
discrepancies in responses to different questions about wheez-
ing in the present study. However, it has been reported that
parental-reported wheezing in early life is imprecise23 and
correlates poorly with objective observations24 or with wheeze
assessed by health professionals.25 Reassuringly, we found
extremely strong associations (ORs up to 326) between
wheezing phenotypes and physician-diagnosed asthma reported
at age 91 months. Because we had up to seven observations of
wheeze, and because the latent class approach allows for
misclassification, lack of reliability of parental reporting of
wheeze appears not to have been a problem in this study.
We did not have reliable data on treatment for wheeze in
early life, although recent studies have suggested that treatmentTa
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with inhaled corticosteroids in infancy does not alter the
natural history of wheezing illnesses in children.26 27 However, it
is conceivable that treatment suppressed symptoms of wheeze
completely in some subjects, which may have biased reporting
towards those with more severe symptoms. Alternatively,
suppression of symptoms by treatment with inhaled steroids
may have contributed to misclassification of phenotypes that
were based on parental-reported wheeze. As this is likely to
have affected those phenotypes with the strongest associations
with doctor-diagnosed asthma, we would have expected such
an effect to attenuate differences between these and other
phenotypic groups rather than to lead to spurious associations
with objective outcomes. We plan to investigate markers of
severity within phenotypes in future studies.
Our finding that the intermediate and late onset phenotypes
had the strongest associations with atopy is consistent with a
critical window of immunological responses28 during which
environmental influences, such as allergens29 30 or viral respira-
tory infections,31 interact with genetic variants in immune
responsiveness to influence the risk of developing asthma and
allergy.32 The association of late onset wheezing with grass
pollen sensitisation may also represent a complex interplay of
environmental exposures and genetic predisposition with the
later onset of symptoms related to seasonal as opposed to
ubiquitous allergen exposure.
Transient early wheezing has been associated with reduced
lung function soon after birth, and there is evidence from
several studies that such deficits are likely to improve partially
in later childhood, although may continue to track below
normal values.5 18 33 Early postnatal measurements were not
available in our study but, based on this literature, it seems
plausible that early decrements of lung function were associated
with the three early onset wheezing phenotypes which were
less strongly associated with atopy and airway responsiveness
than later onset wheezing. Reduced lung function soon after
birth is associated with asthma34 and airway responsiveness35 in
later childhood. Our finding of mid-childhood lung function
decrements in children with prolonged early and persistent
wheezing could reflect persistence of developmental airway
abnormalities, but is also consistent with allergenic or non-
allergenic postnatal exposures aggravating existing structural
airway abnormalities in subgroups of early onset wheeze. The
importance of such decrements in mid-childhood is that, once
established, they are likely to persist to adulthood.3 5
In summary, the childhood wheezing phenotypes most
strongly associated with atopy and airway responsiveness in
our study were characterised by onset of wheezing after the age
of 18 months. Wheezing onset soon after birth was not
associated with atopy or airway responsiveness except when
it persisted to later childhood. Persistent wheeze may represent
a complex phenotype comprising different pathophysiological
components encompassing early structural or functional airway
changes modified by inflammatory processes during early
childhood. Environmental influences on the initiation of atopic
wheezing or which modify existing wheezing phenotypes are
likely to have a major influence during the first years after birth.
The search for modifiable factors that account for the rise in
asthma and allergic diseases in industrialised countries36 should
focus on interactions between genes and environment during
this critical period. The availability of early environmental data
in the ALSPAC cohort will enable these associations to be
examined in relation to the phenotypes described here.
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An unusual cystic lung lesion
CLINICAL PRESENTATION
An 80-year-old man was admitted because he had experienced
haemoptysis for 4 days. He had smoked 40 cigarettes daily for
50 years. He had no medical history except for chronic obstructive
pulmonary disease. Physical examination and laboratory data were
unremarkable. A chest radiograph revealed a mass lesion in the
right upper lobe of the lung. A CT scan of the patient’s chest (fig 1A)
showed a well defined cystic mass with mural nodules in the medial
aspect of the right upper lung. Magnetic resonance imaging (MRI)
of the chest showed a well defined cystic mass with multiple mural
nodules in the right upper lung zone, 567.567.5 cm in size (fig 1B).
A CT-guided biopsy was performed and the pathology of the
specimen indicated chronic inflammation.
QUESTION
What is your diagnosis?
See page 1005
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Figure 1 (A) CT scan of the chest
showing a well defined cystic mass with
mural nodules 1067.567.0 cm in the
medial aspect of the right upper lung.
There were no enlarged mediastinal or
hilar nodes. (B) MRI of the thorax
showing a well defined cystic mass with
mural nodules 8.567.567.5 cm in the
right upper lung.
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